All stock lists
Unlock the score
AIM ImmunoTech Inc. (New York Stock Exchange Arca:AIM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.17+0.01 (+7.68%)
Insider Score
/ 100
AIM Insider Score
AIM ImmunoTech Inc. has a live Insider Score.
Scored on 6 qualifying trades from 1 insider in the last 90 days.
AIM analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on AIM that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering AIM
No firm covering AIM has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AIM earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-27 | -0.94 | -1.36 | $100K | $21K |
| 2026-05-15 | -1.08 | -0.69 | $11K | $11K |
| 2026-08-07 | -0.17 | -0.43 | $100K | $26K |
| 2026-11-16 | -0.09 | 0.00 | $26K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.